chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Axillary lymph vessels under left armpit swollen 5 cm and tender Cervical lymph nodes nodule swollen 2 cm and tender; Axillary lymph vessels under left armpit swollen 5 cm and tender. Cervical lymph nodes nodule swollen 2 cm and tender; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 03Feb2022 10:15 (Lot number: FK9896) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EJ1686, Location of injection: Arm Left, Vaccine Administration Time: 12:00, Route of Administration: Intramuscular), administration date: 04Feb2021, when the patient was 45 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EJ1686, Location of injection: Arm Left, Vaccine Administration Time: 03:15 PM, Route of Administration: Intramuscular), administration date: 14Jan2021, when the patient was 45 years old, for COVID-19 immunization.  The following information was reported: LYMPHADENOPATHY (non-serious) with onset 04Feb2022 12:15, outcome "recovering", described as "Axillary lymph vessels under left armpit swollen 5 cm and tender Cervical lymph nodes nodule swollen 2 cm and tender"; LYMPH NODE PAIN (non-serious) with onset 04Feb2022 12:15, outcome "recovering", described as "Axillary lymph vessels under left armpit swollen 5 cm and tender. Cervical lymph nodes nodule swollen 2 cm and tender". Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain.  Additional information: The patient had no other vaccine in four weeks. No other medications in two weeks. The patient received no covid prior vaccination and was not tested for covid post vaccination. The patient had no known allergies.   No follow-up attempts are possible. No further information is expected.
1625-C/O dizziness, headache, & sweating. BP 203/117, pulse 90, RR 18, O2 sat 95% on RA. Cold compress applied to nape of neck, feet elevated in chair, given water to drink. 1640- BP 159/125, pulse 83, RR 18, O2 sat 95% on RA.  Given time to relax & rest. 1655-BP 148/103, pulse 88, RR 18, O2 sat 96% on RA.  1710- BP 138/96, pulse 77, RR16, O2 sat 97% on RA. States symptoms are resolved & he feels a lot better & his SBP usually runs in the 130s & DBP in the 90s. Encouraged to F/U with primary physician & if symptoms reoccur report to Urgent  Care or ER, immediately. Verbalized understanding.
Shortness of breath; Got really sick on it/was constantly getting sick all day; Headache; Nausea/like a fire hose all over the house from one bathroom to another bathroom; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ILLNESS (Got really sick on it/was constantly getting sick all day), HEADACHE (Headache) and NAUSEA (Nausea/like a fire hose all over the house from one bathroom to another bathroom) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath), ILLNESS (Got really sick on it/was constantly getting sick all day), HEADACHE (Headache) and NAUSEA (Nausea/like a fire hose all over the house from one bathroom to another bathroom). At the time of the report, DYSPNOEA (Shortness of breath), ILLNESS (Got really sick on it/was constantly getting sick all day), HEADACHE (Headache) and NAUSEA (Nausea/like a fire hose all over the house from one bathroom to another bathroom) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       Concomitant medications details were not reported by the reporter.  Treatment medication included unspecified pills to help with the nausea.  Patient took second dose on 17 May 2021 and did not experience any events. Patient's Moderna booster was on 17-Nov-2021.   This case was linked to MOD-2021-395817.
Patient experienced a delayed injection site reaction after their first Moderna immunization on 3.6.2021. 9 days post 1st immunization the patient experienced rash, warmth, and tingling. Patient did recover and was able to get second immunization.
This spontaneous report as received from a register nurse refers to a 2 months infant, of unknown gender. Medical history and concurrent conditions were not reported. On 26-FEB-2014, the patient was vaccinated with first dose of ROTATEQ, lot #J007283; expiration date: 27-SEP-2014 (dose and strength were not reported. Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored ROTATEQ was administered to patient. No adverse effects reported. The nurse reported that vaccine dose received by patient was a vaccine improperly stored as follows: On 13-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, ROTATEQ the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reported. Additional information has been requested.
3 cm area of erythema and swelling on right arm with tenderness to palpation
high pitched screaming for 3 1/2 hrs following immun; unconsolable; t100; would not nurse;
This case was reported by a pharmacist via call center representative and described the occurrence of pain in a adult male patient who received SHINGRIX (batch number YS53Y, expiry date January 2020). On 22nd March 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced pain and adverse event. On an unknown date, the outcome of the pain and adverse event were unknown. It was unknown if the reporter considered the pain and adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX in left arm. The health care professional stated that the patient felt like someone punched him in the arm. The reporter was the patient and the health care professional reported a total of 4 adverse events during call.
Patient developed shingles.  Started on Valtrex 1g po BID for 10 days  Started on gabapentin 100mg po TID for pain management
Patient was referred to the ED by his cardiologist for bradycardia. Patient underwent a procedure to have pacemaker placed. He remains hospitalized at this time. Per the EUA, hospitalizations are to be reported irrespective of attribution to vaccine.
I felt dizzy and lightheaded right after the shot. That night my arm was hurting me very badly. I started to feel feverish and extremely fatigued the next day. I also felt achy. I have intermittent very mild headaches and just feel lousy.
8 cm. welt tender and itchy (Hep A area) > Right arm.
Flu like symptoms the night of first dose.  Woke up the next morning with migraine type headache, pain in hips and knees. Fatigue.
Shaking chills, extreme fatigue, headache, neck pain, photo sensitivity, injection site pain, nausea, fever 101.2 to 103.5F, tachycardia at 120 bpm and dizziness.  Worst of all is the moderate to severe pain concentrated in my quadriceps and hips/back pain. I also have generalized muscle aches. I had polio as a child and the leg pain felt very much like a triggered post polio event, only worse than in the past. All of these symptoms are still ongoing except for the shaking chills. It?s now 32 hours post -dose.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not provided. On 22-FEB-2017, the patient was vaccinated with an expired dose of GARDASIL (lot # K006960, expiration date: 19-FEB-2017, dose and route were unknown) for prophylaxis.  No adverse effects were reported. Additional information has been requested.
ACUTE RESPIRATORY FAILURE 9/8/2021 OSTEOMYELITIS ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/29/2021 OSTEOMYELITIS HYPOXIA 7/26/2021 OSTEOMYELITIS ACUTE RESPIRATORY FAILURE 9/8/2021 ANEMIA OF CHRONIC DISEASE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/29/2021 ANEMIA OF CHRONIC DISEASE HYPOXIA 7/26/2021 ANEMIA OF CHRONIC DISEASE ACUTE RESPIRATORY FAILURE 9/8/2021 CANCER METASTATIC TO BONE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/29/2021 CANCER METASTATIC TO BONE HYPOXIA 7/26/2021 CANCER METASTATIC TO BONE ACUTE RESPIRATORY FAILURE 9/8/2021 CHRONIC OSTEOMYELITIS OF UNSPECIFIED BONE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/29/2021 CHRONIC OSTEOMYELITIS OF UNSPECIFIED BONE HYPOXIA 7/26/2021 CHRONIC OSTEOMYELITIS OF UNSPECIFIED BONE
Pt received PREVNAR 13 on 1/29/17. Patient noticed redness and itching on 12/4/17 and took a Zyrtec OTC for one dose. The patient noticed the redness and rash increasing and came to the pharmacy on 2/5/17. The RPh on duty called the on call MD and he instructed her to take a dose of Benadryl and followup with primary care MD in the morning.
allergic reaction; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program and medical information team. A female patient of an unspecified age (age: 80; unit: unknown) received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein), via an unspecified route of administration on an unspecified date at single dose for immunization. Medical history included allergic to eggs and having a sensitivity to formaldehyde and phenol from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced an allergic reaction to the pneumonia vaccine on unspecified date. The outcome of the event was unknown.  No follow-up attempts are needed. Information regarding batch and lot number cannot be obtained.
This spontaneous report as received from a medical assistant refers to 3 unspecified patients of unknown age and gender. The patients' concurrent conditions and medical history were not provided. On unknown dates, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX lot # L041207, expiry date: 20-OCT-2017 (dose#, route and site of administration not reported). Concomitant medication was not mentioned. No adverse effects were reported. No further information was provided. Product quality complaint was not filed. Additional information has been requested. This is one of the six reports received from the same reporter.
RASH; MUSCLE CRAMPS; CHILLS; FEVER; HEADACHE; NAUSEA; MUSCLE ACHES; JOINT PAIN; FATIGUE; VOMITING; INSOMNIA; LACK OF APPETITE; STOMACH CRAMPS; This spontaneous report received from a patient concerned a 21 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, non smoker, and occasional alcohol drinking, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. Concomitant medications included ibuprofen. On 12-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced insomnia. On 12-APR-2021, the subject experienced lack of appetite. On 12-APR-2021, the subject experienced stomach cramps. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced nausea. On 12-APR-2021, the subject experienced muscle aches. On 12-APR-2021, the subject experienced joint pain. On 12-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced muscle cramps. On 20-APR-2021, the subject experienced rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, insomnia, chills, headache, and nausea on 13-APR-2021, lack of appetite, muscle aches, and fatigue on 19-APR-2021, stomach cramps on 16-APR-2021, and fever on 14-APR-2021, was recovering from rash, and had not recovered from joint pain, and muscle cramps. This report was non-serious.
10 days after vaccination presented to ER x 2 with  (L) side chest pain and (L) arm pain. Presented to our office on 10/27/14 with typical rash of shingles - this appears to be a classic presentation of shingles on the (L) side. Treated with prednisone and hydrocodone.
bump, swelling; twitching right arm; psoriasis, legs, feet elbow, back, arms; pain at injection site right arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (bump, swelling), MUSCLE TWITCHING (twitching right arm), PSORIASIS (psoriasis, legs, feet elbow, back, arms) and VACCINATION SITE PAIN (pain at injection site right arm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PERIPHERAL SWELLING (bump, swelling), MUSCLE TWITCHING (twitching right arm), PSORIASIS (psoriasis, legs, feet elbow, back, arms) and VACCINATION SITE PAIN (pain at injection site right arm). On 28-Mar-2021, PERIPHERAL SWELLING (bump, swelling) and VACCINATION SITE PAIN (pain at injection site right arm) outcome was unknown. At the time of the report, MUSCLE TWITCHING (twitching right arm) and PSORIASIS (psoriasis, legs, feet elbow, back, arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and treatment medications were reported.
Information has been received from a nurse concerning a 45 year old male who on 09-SEP-2008 was vaccinated with ZOSTAVAX (Merck).  There was no concomitant medication.  On 11-SEP-2008, two days after receiving vaccine, the patient developed shingles.  The patient sought medical attention as an office visit.  He reported that the outbreak was minimal with no pain and only itching.  The duration of the blister like rash was "a couple of days" and only a red spot described as centimeter in length remains at the rash site (right lower back).  No other symptoms or treatment reported.
05/06/2003:  IPV, DTaP, and Hib given.  Mom states that within 2-3 hours after immunizations, child had fever, progressed to convulsions and LOC.  Hospitalized for 3 days, told "vaccine-related".  **Very late report due to resignation of nurse who administered.  Incomplete VAERS report found in desk of resigned employee. Medical Receords received on 1/25/2005 states febrile seizure was final diagnosis. Other symptoms were URI symptoms of runny nose and cough, transient elevation of glucose level to 158 (norm 70-109), and coagulase negative staph (small & large) on blood cultures.
Bivalent vaccine was administered as Primary series dose 1.  No adverse event reported, but wrong vaccine for primary series
New diagnosis of gallbladder cancer made on 12/14/21 following routine cholecystectomy.  Evaluation for upper epigastric pain began in August, 2021 with finding of gallbladder sludge and recommendation for cholecystectomy.  Liver resection surgery completed on 1/5/22, currently undergoing chemotherapy with capecitabine.  This is not felt to be an adverse reaction to the vaccine, but is being reported for completeness.
Resident found on floor beside chair, unable to rouse. Blood Sugar upon paramedics arrival to facility of 66, blood sugar reported by hospital upon emergency department arrival of 18. Emergency Department discovered Urinary Tract Infection present, resident admitted to hospital and discharged from hospital to rehabilitation skilled nursing facility.
NAUSEA; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea. This report was non-serious.
I have felt extremely lethargic and exhausted since vaccine, but today noted some supraclavicular lymph node enlargement and mild submandibular lymph node enlargement on the same side as the vaccine was given
WITHIN A FEW MINUTES AFTER VACCINE PATIENT COMPLAINED OF LIGHT HEADEDNESS.  FACE WAS FLUSHED, SKIN CLAMMY AND HAD SLIGHT RED RASH ON FOREARMS.  FIVE MINUTES LATER PATIENT COMPLAINED OF CHEST TIGHTNESS AND SEVERE HEADACHE WITH PAIN OF 8 OUT OF 0-10 PAIN SCALE.  PUPILS WERE DILATED WITH SLIGHT CONFUSION NOTED.  VITAL STATS TAKEN AT 3:33  BP 143/77, P 132 AT 3:40 BP 184/133 P 90 R22 EMS CALLED AT THIS TIME.  HAD PATIENT LAY DOWN ON FLOOR WITH ICE PACK TO BACK OF NECK.  3:47 BP 125/76 P87 R 20 LYING.  3:50 BP 113/67 P90 R 20
vaginal bleeding; This is a spontaneous report from a contactable female patient who reported for herself and her sister. This report is for her sister:  A 50-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: Unknown), via an unspecified route of administration on unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Lot Number: Unknown) via unspecified route of administration on unspecified date as a single dose for COVID-19 immunization. On 10Apr 2021 the patient experienced vaginal bleeding. Caller states her sister is experiencing vaginal bleeding, states that she started bleeding on Saturday, 10Apr2021 and has not stopped, states she knows there have been reports of this being a possible side effect of the vaccine. Caller wants to know if this is a side effect of the vaccine. How long this may last. The outcome of the reported event was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : -PFIZER INC-2021401446 same reporter/drug/AE, different patients
1/12/2021 this employee came into office showing that she had a reddened area to her right Deltoid.  It was approximately 2 inches wide and 1.5 inches long.  It was hard when palpated and it was itching.  It did not show  up until this day which was 8 days post vaccination.  Instructed to take Benedryl at bedtime and then come back to assess.  1/13/2021 this employee came back and the area of redness had increased but was less red and was not itching.  Measurements of 2 inches x 2 inches were present for redness.  The tissue was now soft instead of the harness felt yesterday.
Information has been received from a registered nurse referring to a patient of unknown age and gender. No patient's concurrent conditions or medical history were provided. On 17-MAR-2016, the patient was vaccinated with dose of improperly stored (temperature: 12 degrees Celsius, time frame: 8.5 hours) MMR II (lot# L012482, expiry date: 10-APR-2017, dose, route and site of administration were unspecified). There was no temperature excursion issues previously. Concomitant medication was not reported. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
first shot, just some soreness of her arm; This is a spontaneous report from a contactable consumer. A 55-year-old female patient received first dose bnt162b2 (BNT162B2), via an unspecified route of administration on 18Mar2021 (Batch/Lot Number: EM0204) as single dose for COVID-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient received her first shot on 18Mar2021. She had nothing really with the first shot, just some soreness of her arm. The outcome of the events was recovered on 21Mar2021.  No follow-up attempts are needed. No further information is expected.